Image de couverture de livre

Assessing state‐of‐the‐art online large language models for patient education regarding prostatitis

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Pengfei Zhang, Hui Wang, Pengfei Li, Xianchun Fu, Hang Yuan, Hongwei Ji, Haitao Niu
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	The Prostate
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Performance of large language models on benign prostatic hyperplasia frequently asked questions
par: YuNing Zhang, et autres
Publié: (2024)

Responses to queries concerning “Performance of large language models on benign prostatic hyperplasia frequently asked questions”
par: YuNing Zhang, et autres
Publié: (2024)

An orthotopic prostate cancer model for new treatment development using syngeneic or patient‐derived tumors
par: Naz Chaudary, et autres
Publié: (2024)

The role of gut microbiota involved in prostate microenvironment and symptoms improvement in chronic prostatitis/chronic pelvic pain syndrome patients treated with low‐intensity extracorporeal shock wave
par: Xiangbin Kong, et autres
Publié: (2024)

Predicting abiraterone efficacy in advanced prostate cancer: Insights from marker of proliferation Ki67
par: Fengnian Zhao, et autres
Publié: (2024)

Testosterone bounce predicts favorable prognoses for prostate cancer patients treated with degarelix
par: Shuhei Kamada, et autres
Publié: (2024)

Modern predictors and management of incidental prostate cancer at holmium enucleation of prostate
par: Eric V. Li, et autres
Publié: (2024)

Estimating disparities of prostate cancer burden and its attributable risk factors for males across the BRICS‐plus, 1990–2019: A comparable study of key nations with emerging economies
par: Li‐Sha Luo, et autres
Publié: (2024)

Predicting clinically significant prostate cancer in elderly patients: A nomogram approach with shear wave elastography
par: Xiang Liu, et autres
Publié: (2024)

Consistent predictive ability of prostate‐specific antigen density prediction model for clinically significant prostate cancer across age strata
par: Kamil Malshy, et autres
Publié: (2024)

Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancer
par: Catherine H. Marshall, et autres
Publié: (2024)

Bellmunt risk score as a survival predictor in patients with metastatic castration‐resistant prostate cancer
par: Thomas Büttner, et autres
Publié: (2024)

The detection rate for prostate cancer in systematic and targeted prostate biopsy in biopsy‐naive patients, according to the localization of the lesion at the mpMRI: A single‐center retrospective observational study
par: Matteo Massanova, et autres
Publié: (2024)

FOXA1 regulates ribosomal RNA transcription in prostate cancer
par: Tianwei Jia, et autres
Publié: (2024)

Differences in real‐world outcomes by risk classification for localized prostate cancer patients after radiation therapy
par: Lawrence Karsh, et autres
Publié: (2024)

Impact of presentation timing in metastatic hormone‐sensitive prostate cancer: Characterization of patients and identification of prognostic factors
par: Juliana Arenas Hoyos, et autres
Publié: (2024)

Effects of oral administration of nonselective Trk inhibitor on bladder overactivity in rodent models of prostatic inflammation
par: Taro Igarashi, et autres
Publié: (2024)

Real‐world prevalence of adverse events with first‐line systemic therapies among patients with metastatic castration‐sensitive prostate cancer
par: Umang Swami, et autres
Publié: (2024)

Does larger prostate size provide protection for cancer specific outcomes in localized prostate cancer
par: Zain Abedali, et autres
Publié: (2024)

Cutibacterium acnes invades prostate epithelial cells to induce BRCAness as a possible pathogen of prostate cancer
par: Shingo Ashida, et autres
Publié: (2024)

Analysis of three primary prostatic sarcoma cases and literature review
par: Yirui Wei, et autres
Publié: (2024)

Impact of proton pump inhibitors on the efficacy of androgen receptor signaling inhibitors in metastatic castration‐resistant prostate cancer patients
par: Tokiyoshi Tanegashima, et autres
Publié: (2024)

Prognostic model for second progression‐free survival and overall survival in patients with high‐risk metastatic hormone‐sensitive prostate cancer treated with abiraterone acetate and androgen deprivation therapy
par: Shintaro Narita, et autres
Publié: (2024)

Serum levels of prostate specific antigen, free PSA, [−2]proPSA, fPSA/tPSA ratio, Prostate Health Index, and glycosylation patterns of free PSA in patients with benign prostatic hyperplasia pharmacotherapy
par: Michal Jirásko, et autres
Publié: (2024)

Diagnosis and management of neuroendocrine prostate cancer
par: Ivan de Kouchkovsky, et autres
Publié: (2024)

Impact of definitive radiotherapy on metabolic response measured with 68Ga‐PSMA‐PET/CT in patients with intermediate‐risk prostate cancer
par: Cem Onal, et autres
Publié: (2024)

Prognostic value of circulating tumor cells in oligorecurrent hormone‐sensitive prostate cancer patients undergoing stereotactic body radiation therapy
par: Fabio Matrone, et autres
Publié: (2024)

Efficacy, tolerability, and safety of teverelix DP in patients with advanced prostate cancer: A multicenter, open‐label, phase 2 trial
par: Albertas Ulys, et autres
Publié: (2024)

Incidence and risk factors of prostate cancer among the Northern and Eastern parts of the United Arab Emirates population
par: Jian Wang, et autres
Publié: (2024)

Other‐cause mortality in incidental prostate cancer
par: Francesco Di Bello, et autres
Publié: (2024)

Influence of microbiome in intraprostatic inflammation and prostate cancer
par: Pranav Prakash, et autres
Publié: (2024)

The predictive impact of hematological inflammatory markers in detecting prostate cancer in patients with PI‐RADS 3 lesions on multiparametric magnetic resonance imaging
par: Ridvan Kayar, et autres
Publié: (2024)

A body shape index (ABSI) but not body mass index (BMI) is associated with prostate cancer‐specific mortality: Evidence from the US NHANES database
par: Hui‐Chen Ku, et autres
Publié: (2024)

Reply to Letter to the Editor on “Impact of proton pump inhibitors on the efficacy of androgen receptor signaling inhibitors in metastatic castration‐resistant prostate cancer patients”
par: Tokiyoshi Tanegashima, et autres
Publié: (2024)

The effect of dose‐escalation radiotherapy with simultaneous‐integrated‐boost on the use of short‐term androgen deprivation therapy in patients with intermediate risk prostate cancer
par: Cem Onal, et autres
Publié: (2024)

Impact of PSA nadir, PSA response and time to PSA nadir on overall survival in real‐world setting of metastatic hormone‐sensitive prostate cancer patients
par: Mike Wenzel, et autres
Publié: (2024)

Translation and validation of a lifestyle questionnaire related to prostate cancer
par: Reyhane Karegar‐Niavol, et autres
Publié: (2024)

External validation of the Memorial Sloan Kettering Cancer Center preoperative nomogram predicting lymph node invasion in a cohort of high‐grade prostate cancer patients
par: Nawar Touma, et autres
Publié: (2024)

A novel HDAC6 inhibitor interferes microtubule dynamics and spindle assembly checkpoint and sensitizes cisplatin‐induced apoptosis in castration‐resistant prostate cancer
par: Pei‐Chen Ye, et autres
Publié: (2024)

Key learnings from concordant systematic biopsies in prostate‐specific membrane antigen positron emission tomography/computed tomography‐guided prostate biopsies: Enhancing targeting accuracy
par: Thomas Büttner, et autres
Publié: (2024)